β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Top Cited Papers
- 22 March 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 393 (10181), 1597-1608
- https://doi.org/10.1016/s0140-6736(18)31875-0
Abstract
No abstract availableFunding Information
- Instituto de Salud Carlos III (EC08/00087, PI10/01552, PI13/02535, PS09/00485, PI14/00876, and PI15/00066)
This publication has 29 references indexed in Scilit:
- The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative studyHepatology, 2011
- Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort studyHepatology, 2009
- The clinical use of HVPG measurements in chronic liver diseaseNature Reviews Gastroenterology & Hepatology, 2009
- Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedHepatology, 2009
- Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic ReviewGastroenterology, 2006
- Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis CHepatology, 2006
- The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the MoleculeHepatology, 2006
- Beta-Blockers to Prevent Gastroesophageal Varices in Patients with CirrhosisNew England Journal of Medicine, 2005
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2005
- Endoscopic Ligation Compared with Combined Treatment with Nadolol and Isosorbide Mononitrate to Prevent Recurrent Variceal BleedingNew England Journal of Medicine, 2001